This content is not available in your region

Healthcare group Sanofi forms research deal with the company Exscientia

Healthcare group Sanofi forms research deal with the company Exscientia
Healthcare group Sanofi forms research deal with the company Exscientia   -   Copyright  Thomson Reuters 2022
By Reuters

PARIS – French healthcare company Sanofi, which has been under pressure to revive its drug pipeline after some setbacks in the COVID-19 vaccine race, announced on Friday a research deal with the company Exscientia to develop new medicines.

The two companies said they would work on developing an artificial-intelligence (AI) driven pipeline of new products in areas such as oncology and immunology.

Exscientia will also receive an upfront cash payment of $100 million with the potential of $5.2 billion in total milestones plus tiered royalties, as part of the deal with Sanofi.